Medex Consulting Pty Ltd secures contract for Procurement of clinical input to support the MSAC application seeking to expand MBS items 73296 and 73297 to include germline testing for individuals with prostate cancer and cascade testing for biological relatives

Australia, May 1 -- Australia based Medex Consulting Pty Ltd has secured contract from Cancer Australia for Procurement of clinical input to support the MSAC application seeking to expand MBS items 73296 and 73297 to include germline testing for individuals with prostate cancer and cascade testing for biological relatives. The value of the contract is worth 19,250.00 AUD.

Published by HT Digital Content Services with permission from Pivotal Sources....